Etravirine
ATC Code
J05AG04
Etravirine
Definition
A diarylpyrimidine non-nucleoside reverse transcriptase inhibitor. Etravirine is designed to be active against HIV isolates with mutations that confer resistance to the two most commonly prescribed first-generation NNRTIs. It can bind the enzyme reverse transcriptase (RT) in multiple conformations, both for native and mutant RT, thereby blocking the enzymatic activity of RT.
Also known as 4-(6-Amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile, ETRAVIRINE, ETV, Intelence, TMC-125 — per NCIT
Also identified as
- ATC J05AG04 per RXNORM
- NCIT NCIT:C73195 per NCIT
- SCTID 432121008 per RXNORM
- SCTID 432221004 per RXNORM
- UNII 0C50HW4FO1 per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| HIV infectious disease | may treat | MEDRT · Public domain (U.S. Government work) |